These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35078987)

  • 1. Systematic decomposition of sequence determinants governing CRISPR/Cas9 specificity.
    Fu R; He W; Dou J; Villarreal OD; Bedford E; Wang H; Hou C; Zhang L; Wang Y; Ma D; Chen Y; Gao X; Depken M; Xu H
    Nat Commun; 2022 Jan; 13(1):474. PubMed ID: 35078987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification-free long-read sequencing reveals unforeseen CRISPR-Cas9 off-target activity.
    Höijer I; Johansson J; Gudmundsson S; Chin CS; Bunikis I; Häggqvist S; Emmanouilidou A; Wilbe M; den Hoed M; Bondeson ML; Feuk L; Gyllensten U; Ameur A
    Genome Biol; 2020 Dec; 21(1):290. PubMed ID: 33261648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage.
    Riesenberg S; Helmbrecht N; Kanis P; Maricic T; Pääbo S
    Nat Commun; 2022 Jan; 13(1):489. PubMed ID: 35078986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
    Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
    J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 off-targeting assessment with nucleic acid duplex energy parameters.
    Alkan F; Wenzel A; Anthon C; Havgaard JH; Gorodkin J
    Genome Biol; 2018 Oct; 19(1):177. PubMed ID: 30367669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified CRISPR-Mediated DNA Editing in Multicellular Eukaryotes.
    Kumar R; Tiwari K; Saudagar P
    Methods Mol Biol; 2023; 2575():241-260. PubMed ID: 36301478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPRseek: a bioconductor package to identify target-specific guide RNAs for CRISPR-Cas9 genome-editing systems.
    Zhu LJ; Holmes BR; Aronin N; Brodsky MH
    PLoS One; 2014; 9(9):e108424. PubMed ID: 25247697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing sgRNA length to improve target specificity and efficiency for the GGTA1 gene using the CRISPR/Cas9 gene editing system.
    Matson AW; Hosny N; Swanson ZA; Hering BJ; Burlak C
    PLoS One; 2019; 14(12):e0226107. PubMed ID: 31821359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WheatCRISPR: a web-based guide RNA design tool for CRISPR/Cas9-mediated genome editing in wheat.
    Cram D; Kulkarni M; Buchwaldt M; Rajagopalan N; Bhowmik P; Rozwadowski K; Parkin IAP; Sharpe AG; Kagale S
    BMC Plant Biol; 2019 Nov; 19(1):474. PubMed ID: 31694550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Assays for Comparing the Specificity of First- and Next-Generation CRISPR/Cas9 Systems.
    Cromwell CR; Hubbard BP
    Methods Mol Biol; 2021; 2162():215-232. PubMed ID: 32926385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities and specificities of CRISPR/Cas9 and Cas12a nucleases for targeted mutagenesis in maize.
    Lee K; Zhang Y; Kleinstiver BP; Guo JA; Aryee MJ; Miller J; Malzahn A; Zarecor S; Lawrence-Dill CJ; Joung JK; Qi Y; Wang K
    Plant Biotechnol J; 2019 Feb; 17(2):362-372. PubMed ID: 29972722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking.
    Chen X; Tasca F; Wang Q; Liu J; Janssen JM; Brescia MD; Bellin M; Szuhai K; Kenrick J; Frock RL; Gonçalves MAFV
    Nucleic Acids Res; 2020 Jan; 48(2):974-995. PubMed ID: 31799604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision Targeted Mutagenesis via Cas9 Paired Nickases in Rice.
    Mikami M; Toki S; Endo M
    Plant Cell Physiol; 2016 May; 57(5):1058-68. PubMed ID: 26936792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs.
    Lee HJ; Kim HJ; Lee SJ
    Genome Res; 2020 May; 30(5):768-775. PubMed ID: 32327447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for Measuring CRISPR/Cas9 DNA Cleavage in Cells.
    Cromwell CR; Jovel J; Hubbard BP
    Methods Mol Biol; 2021; 2162():197-213. PubMed ID: 32926384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
    Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
    Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 Guide RNA Design Rules for Predicting Activity.
    Hiranniramol K; Chen Y; Wang X
    Methods Mol Biol; 2020; 2115():351-364. PubMed ID: 32006410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.